Journey Medical (DERM) Retained Earnings (2020 - 2026)

Journey Medical's Retained Earnings history runs 7 years deep, the most recent figure standing at $131.5 million for Q1 2026.

• Quarterly Retained Earnings rose 244.36% year-over-year to $131.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.5 million (up 244.36% YoY) and the FY2025 annual result came in at -$98.5 million, down 191.94% from the prior year.
• Retained Earnings was $131.5 million for Q1 2026 at Journey Medical, up from -$98.5 million in the prior quarter.
• Across five years, Retained Earnings topped out at $131.5 million in Q1 2026 and bottomed at -$98.5 million in Q4 2025.
• A 5-year average of $10.2 million and a median of -$40.3 million in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings tumbled 1168.91% — and 2023, when it surged 313.97%.
• Journey Medical's Retained Earnings stood at -$68.5 million in 2022, then surged by 235.33% to $92.7 million in 2023, then rose by 15.52% to $107.1 million in 2024, then slumped by 191.94% to -$98.5 million in 2025, then jumped by 233.58% to $131.5 million in 2026.
• Business Quant data shows DERM's Retained Earnings at $131.5 million in Q1 2026, -$98.5 million in Q4 2025, and $123.1 million in Q3 2025.